Matches in Wikidata for { <http://www.wikidata.org/entity/Q92662655> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q92662655 description "article scientifique publié en 2019" @default.
- Q92662655 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q92662655 description "im September 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92662655 description "scientific article published on 01 September 2019" @default.
- Q92662655 description "wetenschappelijk artikel" @default.
- Q92662655 description "наукова стаття, опублікована 1 вересня 2019" @default.
- Q92662655 name "High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance" @default.
- Q92662655 name "High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance" @default.
- Q92662655 type Item @default.
- Q92662655 label "High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance" @default.
- Q92662655 label "High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance" @default.
- Q92662655 prefLabel "High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance" @default.
- Q92662655 prefLabel "High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance" @default.
- Q92662655 P1433 Q92662655-D8AADC6A-6B48-46D1-968D-1C7B92D68A25 @default.
- Q92662655 P1476 Q92662655-EA39433B-273C-4427-AF86-A2CE535174D1 @default.
- Q92662655 P2093 Q92662655-0BE98E5E-FA91-484B-80D3-A32BEBBC2B8C @default.
- Q92662655 P2093 Q92662655-2AEEC9A6-F45C-4743-A6B4-3CCEAA158123 @default.
- Q92662655 P2093 Q92662655-3024A233-30A1-4ED4-8335-575C35E7516F @default.
- Q92662655 P2093 Q92662655-48862AFC-6CC4-414B-8A6B-C68124683C46 @default.
- Q92662655 P2093 Q92662655-5EF318DD-0FEA-4364-ABE2-60BAB5D8F75B @default.
- Q92662655 P2093 Q92662655-93C53645-B0BD-4B5F-8282-8272C23D0A5B @default.
- Q92662655 P2093 Q92662655-A3220678-7B34-4A39-8D40-84D9DB5B8E9E @default.
- Q92662655 P2093 Q92662655-A652E1F5-0C2C-441C-B178-2B3B9BC4BB9C @default.
- Q92662655 P2093 Q92662655-A8156BB0-294D-42C4-A399-C5AC378BDE37 @default.
- Q92662655 P2093 Q92662655-D086F956-0CC8-4C85-9208-20AE49808604 @default.
- Q92662655 P2093 Q92662655-EAC77006-1243-414F-B8C0-BAF276D93EEA @default.
- Q92662655 P2093 Q92662655-F539E993-2B66-4BA4-82B0-FF7AFA40FE86 @default.
- Q92662655 P304 Q92662655-FC28D73F-1FB2-404C-8E7A-5E103139EB98 @default.
- Q92662655 P31 Q92662655-948550BD-6442-4C5C-A703-05DCB33A8179 @default.
- Q92662655 P356 Q92662655-B99003C7-FDE3-4331-9FE7-6012D610CD40 @default.
- Q92662655 P433 Q92662655-AE86CB37-38E5-4DF7-AD75-0F4317C4CF1A @default.
- Q92662655 P478 Q92662655-B95D5D2D-84FA-493A-8072-DAA21DDE3AF1 @default.
- Q92662655 P50 Q92662655-17604811-1CA3-4FE3-8EAC-D0A3E9BE1817 @default.
- Q92662655 P577 Q92662655-D6EFE80D-F6E9-47C0-9C4B-59E2880C6EB3 @default.
- Q92662655 P698 Q92662655-4A4B090D-4EB2-4627-A88C-66D027D0D9B8 @default.
- Q92662655 P921 Q92662655-55D6E12A-8028-4237-9469-96C45EE4B8B4 @default.
- Q92662655 P921 Q92662655-DE558CE2-1C4D-4EB7-AE65-44FB2485AC76 @default.
- Q92662655 P356 JJZ066 @default.
- Q92662655 P698 30918959 @default.
- Q92662655 P1433 Q15817379 @default.
- Q92662655 P1476 "High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance" @default.
- Q92662655 P2093 "Alain Bitton" @default.
- Q92662655 P2093 "Alex Al Khoury" @default.
- Q92662655 P2093 "Christine Verdon" @default.
- Q92662655 P2093 "Ernest Seidman" @default.
- Q92662655 P2093 "Gary Wild" @default.
- Q92662655 P2093 "Jason Reinglas" @default.
- Q92662655 P2093 "Kelita Singh" @default.
- Q92662655 P2093 "Lorant Gonczi" @default.
- Q92662655 P2093 "Rita Kohen" @default.
- Q92662655 P2093 "Talat Bessissow" @default.
- Q92662655 P2093 "Waqqas Afif" @default.
- Q92662655 P2093 "Zsuzsanna Kurti" @default.
- Q92662655 P304 "1343-1350" @default.
- Q92662655 P31 Q13442814 @default.
- Q92662655 P356 "10.1093/ECCO-JCC/JJZ066" @default.
- Q92662655 P433 "10" @default.
- Q92662655 P478 "13" @default.
- Q92662655 P50 Q42264535 @default.
- Q92662655 P577 "2019-09-01T00:00:00Z" @default.
- Q92662655 P698 "30918959" @default.
- Q92662655 P921 Q188874 @default.
- Q92662655 P921 Q917447 @default.